论文部分内容阅读
目的针对老年支气管扩张伴大咯血的患者的用药进行了分析,研究酚妥拉明联合垂体后叶素对其的治疗效果。方法选择在2010年6月~2013年7月在本院接受治疗的90例老年支气管扩张伴大咯血患者,将其按照住院的顺序随机分为两组,即对照组与治疗组,每组均为45例患者。两组患者首先进行常规治疗的同时对照组患者给予垂体后叶素进行治疗。治疗组在对照组的基础上联合使用垂体后叶素,在治疗结束后对比治疗组与对照组的疗效以及其不良反应发生率。结果在治疗结束后,对照组患者的总有效率为77.7%,治疗组患者的总有效率为93.3%,两组患者的有效率进行比较发现,治疗组明显优于对照组,差异具有统计学意义(P<0.05)。同时对照组患者的不良反应发生率高于治疗组,差异具有统计学意义(P<0.05)。结论采用酚妥拉明联合垂体后叶素对老年支气管扩张伴大咯血进行治疗,疗效显著,不良反应发生率低,值得在临床中推广使用。
Objective To analyze the medication of elderly patients with bronchiectasis and hemoptysis, and to study the therapeutic effect of phentolamine combined with pituitrin on it. Methods 90 elderly patients with bronchiectasis and hemoptysis who were treated in our hospital from June 2010 to July 2013 were randomly divided into two groups according to the order of hospitalization: control group and treatment group, each group For 45 patients. Patients in both groups were treated with pituitrin for the first time while the control group was treated routinely. The treatment group was treated with pituitrin on the basis of the control group, and the curative effect and the incidence of adverse reactions were compared between the treatment group and the control group after the treatment. Results At the end of treatment, the total effective rate of the control group was 77.7%, and the total effective rate of the treatment group was 93.3%. The comparison of the effective rates of the two groups showed that the treatment group was significantly better than the control group, the difference was statistically significant Significance (P <0.05). The incidence of adverse reactions in the control group was higher than that in the treatment group, the difference was statistically significant (P <0.05). Conclusion Phentolamine combined with pituitrin for the treatment of elderly bronchiectasis with massive hemoptysis, significant effect, the incidence of adverse reactions is low, it is worth promoting in the clinic.